Switzerland related news

Swiss news
New Call for Innovation Partnership Grants with Japan – Deadline 30 July

A new call for Innovation Partnership Grants between Swiss academia and Japanese innovation agents including industry and start-ups is now open. All scientific disciplines including social sciences and humanities are eligible. Selected projects will receive funding up to 20k CHF for a duration of up to 12 months.

Chugai Starts Phase III Clinical Trial of Actemra for COVID-19 Pneumonia in Japan
Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that it is working to start a Phase III clinical trial in Japan with the humanized anti-human IL-6 receptor monoclonal antibody, “Actemra® Intravenous Infusion 80 mg, 200 mg, and 400 mg” [generic name: tocilizumab (genetical recombination)] in COVID-19 pneumonia.
Numab Therapeutics to receive additional CHF 260M from its Japanese partner
Numab Therapeutics and the Japanese based Ono Pharmaceutical have extended their relationship by executing another research and option agreement to discover and develop a multi-specific antibody drug candidate for the treatment of various cancers. Ono will again pay to Numab up to CHF 260 million in upfront and milestone payments.
Mitsubishi Chemical to Acquire European Engineering Plastics Recycling Companies
Mitsubishi Chemical Corporation recently decided that it will acquire two Swiss engineering plastics recyclers, Minger Kunststofftechnik AG and Minger Plastic AG (collectively, the Minger Group), through its group company Mitsubishi Chemical Advanced Materials as a part of the company’s efforts to promote the circular economy. The acquisition is expected to be completed by the end of February this year.